Study of Investigational Drug in Osteoporosis (MK-0217-908)

PHASE3CompletedINTERVENTIONAL

Enrollment

203

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG

Placebo

tablets

DRUG

ibandronate

50 mg tablets

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092053 - Study of Investigational Drug in Osteoporosis (MK-0217-908) | Biotech Hunter | Biotech Hunter